Gathering patient preferences for gynecologic cancer care locations
Official title: Investigating Attitudes to Gynaecological Rapid Access, Cancer Exclusion and Follow Up Location (GRACEFUL Study)
Run by Somerset NHS Foundation Trust · NCT06920342 · Data updated 2026-11-12
This study is trying to find out where patients with gynecologic cancers in the UK prefer to receive their care to help improve their treatment experience.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 600 (estimated) |
| Sponsor | Somerset NHS Foundation Trust Academic / other |
| Locations | 1 site (Taunton, Somerset) |
| Status | Recruiting |
| Started | March 24, 2025 |
| Main results expected | February 2, 2029 |
| Study ends | February 2, 2029 |
| Registry record updated | April 9, 2025 |
| Trial ID | NCT06920342 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are females aged 18 or over who have been referred for suspected gynecological cancer or have a previous diagnosis of gynecological malignancy.
✕Probably not a fit
Patients who are male or unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to understand the preferences of patients in the UK regarding their place of care for gynecologic cancers. It seeks to gather insights on where patients prefer to receive investigation, treatment, and follow-up care, highlighting the importance of patient-centered approaches in healthcare. Previous pilot work indicated that many patients are dissatisfied with care being co-located with obstetrics and gynecology services. The study will analyze patient feedback to inform potential improvements in service organization.
Why it matters
Potential benefit: If successful, this study could lead to more patient-centered care models for gynecologic cancer treatment.
How similar studies have gone: This approach is novel, as previous work in this area has been limited, indicating a gap in understanding patient preferences.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Female Aged 18 or over Able to give informed consent Have been referred to secondary care with a suspected gynaecological cancer, or have previously been diagnosed with a gynaecological malignancy Exclusion Criteria: \- Male Unable to give informed consent
Where it's running
-
Somerset NHS Foundation Trust
Taunton, Somerset, United Kingdom Recruiting
Study contacts
- Study coordinator: Dr Jo Morrison
- Email: jo.morrison@somersetft.nhs.uk
- Phone: +44 1823342562
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Immunonutrition and Brain Monitoring to See if Delirium Happens After Gynecologic Cancer Surgery
This study tests whether a preoperative immunonutrition scoring plus intraoperative brain monitoring can help predict or relate to postoperative delirium in women aged 65 and older undergoing major gynecologic cancer surgery.
-
Prophylactic subcutaneous drainage after gynecologic cancer surgery
This study tests whether placing a small drain under the skin after gynecologic cancer surgery helps prevent wound problems in women with thicker tissue under the skin.
-
Feasibility of high-dose multimodal prehabilitation for women awaiting gynecologic cancer surgery
This study tests whether a high-dose, multimodal prehabilitation program can be delivered before gynecologic cancer surgery and whether patients prefer in-person, remote, or education-only approaches.
-
Romiplostim N01 plus ATRA for persistent chemotherapy-induced low platelets after remission from gynecologic, breast, or lung cancer
This trial tests whether adding ATRA to Romiplostim N01 helps people keep a safe platelet count after finishing chemotherapy for certain cancers.
-
Sexual well-being in people treated for gynecologic cancer and their partners
This project will follow people with gynecologic cancer and their partners to see if their sexual function changes over time using questionnaires and brief exams.
-
Personalized diet to help women with advanced gynecologic or breast cancer on ADC therapy
This study tests a personalized dietary plan versus general Mediterranean diet guidance in women with advanced gynecologic or breast cancer who are being treated with antibody-drug conjugates to see if nutrition can improve quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.